Trial Profile
A Bioequivalence Study to Compare the Pharmacokinetics of Two Betrixaban Formulations
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs Betrixaban (Primary) ; Betrixaban (Primary)
- Indications Venous thromboembolism
- Focus Pharmacokinetics
- Sponsors Portola Pharmaceuticals
- 06 Oct 2016 Status changed from active, no longer recruiting to completed.
- 06 Nov 2015 New trial record